BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 23947345)

  • 21. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
    Ank N; West H; Bartholdy C; Eriksson K; Thomsen AR; Paludan SR
    J Virol; 2006 May; 80(9):4501-9. PubMed ID: 16611910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional characterization of canine interferon-lambda.
    Fan W; Xu L; Ren L; Qu H; Li J; Liang J; Liu W; Yang L; Luo T
    J Interferon Cytokine Res; 2014 Nov; 34(11):848-57. PubMed ID: 24950142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of induction and action of interferons.
    Content J
    Verh K Acad Geneeskd Belg; 2009; 71(1-2):51-71. PubMed ID: 19739398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type III Interferons in Viral Infection and Antiviral Immunity.
    Zhou JH; Wang YN; Chang QY; Ma P; Hu Y; Cao X
    Cell Physiol Biochem; 2018; 51(1):173-185. PubMed ID: 30439714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Basal interferon signaling and therapeutic use of interferons in controlling rotavirus infection in human intestinal cells and organoids.
    Hakim MS; Chen S; Ding S; Yin Y; Ikram A; Ma XX; Wang W; Peppelenbosch MP; Pan Q
    Sci Rep; 2018 May; 8(1):8341. PubMed ID: 29844362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The interferon antiviral response: from viral invasion to evasion.
    Grandvaux N; tenOever BR; Servant MJ; Hiscott J
    Curr Opin Infect Dis; 2002 Jun; 15(3):259-67. PubMed ID: 12015460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No Love Lost Between Viruses and Interferons.
    Fensterl V; Chattopadhyay S; Sen GC
    Annu Rev Virol; 2015 Nov; 2(1):549-72. PubMed ID: 26958928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNA control of interferons and interferon induced anti-viral activity.
    Sedger LM
    Mol Immunol; 2013 Dec; 56(4):781-93. PubMed ID: 23962477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond Good and Evil: Molecular Mechanisms of Type I and III IFN Functions.
    Dowling JW; Forero A
    J Immunol; 2022 Jan; 208(2):247-256. PubMed ID: 35017214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alpha/beta interferon (IFN-alpha/beta)-independent induction of IFN-lambda1 (interleukin-29) in response to Hantaan virus infection.
    Stoltz M; Klingström J
    J Virol; 2010 Sep; 84(18):9140-8. PubMed ID: 20592090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective Interferon Responses of Intestinal Epithelial Cells Minimize Tumor Necrosis Factor Alpha Cytotoxicity.
    Van Winkle JA; Constant DA; Li L; Nice TJ
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Promotes the Degradation of Components of the Type 1 IFN JAK/STAT Pathway and Blocks Anti-viral ISG Induction.
    Gargan S; Ahmed S; Mahony R; Bannan C; Napoletano S; O'Farrelly C; Borrow P; Bergin C; Stevenson NJ
    EBioMedicine; 2018 Apr; 30():203-216. PubMed ID: 29580840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interferon response circuit: induction and suppression by pathogenic viruses.
    Haller O; Kochs G; Weber F
    Virology; 2006 Jan; 344(1):119-30. PubMed ID: 16364743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-λ in the context of viral infections: production, response and therapeutic implications.
    Hermant P; Michiels T
    J Innate Immun; 2014; 6(5):563-74. PubMed ID: 24751921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lambda-Interferons Inhibit Herpes Simplex Virus Type 2 Replication in Human Cervical Epithelial Cells by Activating the JAK/STAT Pathway.
    Li Z; Lu X; Zhu Y; Cheng P; Liu S; Zhang Y; Tang J; Yang S; Zhou L
    Jpn J Infect Dis; 2017 Jul; 70(4):416-422. PubMed ID: 28250263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular mechanisms for suppression of interferon signal transduction pathways caused by viral infections].
    Fujii N; Yokota S; Yokosawa N; Okabayashi T
    Uirusu; 2004 Dec; 54(2):169-78. PubMed ID: 15745154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon: cellular executioner or white knight?
    Maher SG; Romero-Weaver AL; Scarzello AJ; Gamero AM
    Curr Med Chem; 2007; 14(12):1279-89. PubMed ID: 17504213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host defense, viruses and apoptosis.
    Barber GN
    Cell Death Differ; 2001 Feb; 8(2):113-26. PubMed ID: 11313713
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-stimulated genes: a complex web of host defenses.
    Schneider WM; Chevillotte MD; Rice CM
    Annu Rev Immunol; 2014; 32():513-45. PubMed ID: 24555472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.
    Villenave R; Broadbent L; Douglas I; Lyons JD; Coyle PV; Teng MN; Tripp RA; Heaney LG; Shields MD; Power UF
    J Virol; 2015 Dec; 89(24):12309-18. PubMed ID: 26423940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.